In an unprecedented breakthrough in the infection prevention sector, SINTX Technologies, Inc. has secured a Notice of Allowance from the United States Patent and Trademark Office for their pioneering patent on 'Antipathogenic Fibrous Materials.' This patent offers a wide-ranging protection for SINTX's innovative silicon nitride-based technology that seeks to inactivate pathogens across a multitude of…